Delivering life-changing therapies together
OXB (oxb.com) scores 86 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Manufacturing brands, in the 94th percentile of 12565 Healthcare brands.
OXB is a global contract development and manufacturing organization (CDMO) specializing in viral vector and cell and gene therapy development and manufacturing. With over 25 years of experience, OXB provides end-to-end services from pre-clinical stages through commercial launch, supported by robust quality systems. The company serves biotechnology and pharmaceutical companies worldwide that require process development and GMP manufacturing support for advanced therapies.
| Brand Name | OXB |
|---|---|
| Domain | oxb.com |
| Industry | Healthcare, Manufacturing |
| Main Competitors | Catalent (81/100), Lonza (86/100), Thermo Fisher Scientific (90/100), WuXi AppTec (85/100), FUJIFILM Diosynth Biotechnologies (74/100), Novasep, Charles River Laboratories (69/100) |
Moz Domain Authority 40/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,020,075 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
OXB appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "25+ years enabling the world’s most progressive and successful viral vector therapies. Full service offering, supported by robust quality systems." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on YouTube, LinkedIn, X (Twitter), Facebook, Instagram, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is OXB?", Claude could identify the brand as of October 2026. OXB, formerly Oxford Biomedica, is a UK-based gene and cell therapy company specializing in the development and manufacturing of viral vectors, particularly lentiviral vectors, for gene therapies and vaccines. Best known for Lentiviral vector design, development, and manufacturing for gene and cell therapies, including its role in manufacturing the AstraZeneca COVID-19 vaccine.
When asked "Best brands similar to OXB?", Claude would recommend OXB as of October 2026. It's a well-established and respected name in viral vector manufacturing within the gene therapy space, so it would come up naturally if discussing leaders in that niche.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
OXB's main competitors in Healthcare: Catalent (81/100), Lonza (86/100), Thermo Fisher Scientific (90/100), WuXi AppTec (85/100), FUJIFILM Diosynth Biotechnologies (74/100).
Sources: Brand Analyzer scan
OXB has limited AI-search visibility, scoring 43/100 on Brand Analyzer's AI visibility composite (visibility 35, trust 48, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: OXB official site
OXB offers end-to-end viral vector and cell and gene therapy development and manufacturing services, including process development and GMP manufacturing support spanning pre-clinical research through commercial-stage production.
Sources: OXB official site
OXB scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: OXB official site
OXB is a global cell and gene therapy contract development and manufacturing organization (CDMO) with more than 25 years of experience in viral vector development and manufacturing.
Sources: OXB official site
OXB enables the development and manufacture of viral vector-based and cell and gene therapies for biotechnology and pharmaceutical clients. It provides end-to-end services spanning pre-clinical development through GMP manufacturing and commercial launch, supported by robust quality systems.
Sources: OXB official site
OXB can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: OXB official site
OXB is used by biotechnology and pharmaceutical companies developing cell and gene therapies, particularly those needing viral vector process development and GMP manufacturing support from pre-clinical through commercial stages.
Sources: OXB official site
OXB is known for its long-standing expertise-over 25 years-in enabling viral vector therapies, positioning itself as a trusted CDMO partner for advanced cell and gene therapy programs from pre-clinical through commercial stages.
Sources: OXB official site
OXB scores 43/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
OXB has a limited AI-visibility profile at 43/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (35/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,020,075 (Tranco) and a Moz Domain Authority of 40/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify OXB from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to OXB: Owlet (86/100), Orrick (86/100), Paired (86/100), PeopleKeep (86/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.